Biphasic SMN condensates safeguard stress-induced cytoplasmic mislocalization of splicing RNPs. [PDF]
Riedel YL +3 more
europepmc +1 more source
Modeling the Budget Impact of Disease-Modifying Therapies in Infantile-Onset Spinal Muscular Atrophy. [PDF]
Abuloha S +4 more
europepmc +1 more source
Immune Cell-Specific SMN Expression and Sustained Immune Alterations in Treated Spinal Muscular Atrophy. [PDF]
Tapken I +17 more
europepmc +1 more source
From Genes to Function: Clinical Experience with the Effectiveness and Safety of Risdiplam and Nusinersen in Spinal Muscular Atrophy. [PDF]
Sedighi P +5 more
europepmc +1 more source
Tunable gene control via RNA splicing with a clinically approved small molecule. [PDF]
Mendel M +12 more
europepmc +1 more source
The U1 snRNP protein U1C and Helix H of U1 snRNA are critical for small molecule splicing modulator function. [PDF]
Kuang Z +15 more
europepmc +1 more source
Serum p-tau181 and p-tau217 levels in adolescents and adults with 5q spinal muscular atrophy. [PDF]
Stapf CD +15 more
europepmc +1 more source
Risdiplam Add-On Therapy Following Onasemnogene Abeparvovec in Children With Spinal Muscular Atrophy and 2 SMN2 Copies: A Multi-Center Case Series. [PDF]
Stoltenburg C +4 more
europepmc +1 more source
Risdiplam Impact in Treatment Naïve and Non-Naïve Pediatric and Adult Patients With Spinal Muscular Atrophy. [PDF]
Yee POP +16 more
europepmc +1 more source
Delayed diagnosis and genetic testing in spinal muscular atrophy: a case series. [PDF]
Guo X +7 more
europepmc +1 more source

